Fellows' Directory

Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
 
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.

Find out more and apply for Fellowship.

This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.

Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.

Select the magnifying glass icon to begin any searches.

Filter

Result(s):


Dr Michael Pugsley

Michael K Pugsley, PhD, FBPhS, DSP, Director of Toxicology, Purdue Pharma LP.

Dr Vera Ralevic

Vera Ralevic is Associate Professor and Reader in Cardiovascular Sciences at the School of Life Sciences, Queen’s Medical Centre, University of Nottingham.

Professor Andrew Ramage

I received a BSc in Physiology and Biochemistry in 1970 followed by a MPhil (1973) from Southampton University.

Professor Michael Randall

Professor Michael Randall read Natural Sciences at the University of Cambridge, followed by a PhD in Cardiovascular Pharmacology at Cambridge, graduating in 1989.

Professor Marcus Rattray

Marcus Rattray is Professor of Pharmacology and Head of the School of Pharmacy and Medical Sciences at the University of Bradford.

Professor Peter Redfern

Peter Redfern is Emeritus Professor at the University of Bath.

Dr William Redfern

Will Redfern is Vice President, Quantitative Systems Toxicology and Safety (QSTS) at Certara UK.

Professor Jean Claude Reubi

Jean Claude Reubi obtained his MD in Medicine at the University of Zurich in 1972, joined the Brain Research Institute in Zurich, and then the MRC Pharmacology in Cambridge, UK, (Iversen Group).